Type(s) of Cancer
Leukemia/Lymphoma
Leukemia/Lymphoma
Study Phase
Phase 3
Study Completion Date
2017-09-30
2017-09-30
NCT00557193Uploaded 01-12-2024
Access via NCI by Request
PDS UID: nci-data-530
A Phase III Study of Risk Directed Therapy for Infants With Acute Lymphoblastic Leukemia (ALL): Randomization of Highest Risk Infants to Intensive Chemotherapy +/- FLT3 Inhibition (CEP-701, Lestaurtinib; NSC#617807)
Files: NCT00557193-D1
Data DictionaryNCT00557193-D1-Data-Dictionary_0.pdf
DATANCT00557193-D1-Dataset_0.csv
OTHERREADME.pdf
Files: NCT00557193-D2
Data DictionaryNCT00557193-D2-Data-Dictionary_0.pdf
DATANCT00557193-D2-Dataset.csv
OTHERREADME.pdf
Files: NCT00557193-D3
Data DictionaryNCT00557193-D3-Data-Dictionary_0.pdf
DATANCT00557193-D3-Dataset.csv
OTHERREADME.pdf
Files: NCT00557193-D4
Data DictionaryNCT00557193-D4-Data-Dictionary.pdf
DATANCT00557193-D4-Dataset_0.csv
OTHERREADME.pdf